Share this article
Share this article
ResearchAndMarkets.com s offering.
The global immunoassay market is projected to reach USD 39.0 billion by 2026 from USD 28.4 billion in 2021, at a CAGR of 6.6% during the forecast period.
Market growth is largely driven by the rising incidence of chronic and infectious diseases, technological advancements of immunoassay products, and their massive adoptions. Emerging markets in Asian countries are expected to offer strong growth opportunities for players in the market. In contrast, the stringent regulatory scenario and technical hurdles of the immunoassay products may restrict market growth to a certain extent. The immunoassay market is segmented based on product, technology, specimen, application, end-user, and region.
D) Immunohistochemical staining of COX-2 and iNOS inflammatory factors in liver tissue. (
E and
F) Inflammatory cell expression area
%Data are presented as the mean±SD (n=10). As compared with the normal group,
#
##
P
Global CD19(Antibody) Market Industry Estimates and Insights, 2020 – 2027
A robust database of potential market estimations based on historical data analysis is included in the global market report. It helps consumers to provide quantified details for current market perusal. It is a comprehensive and technical study that focuses on primary and secondary drivers, market share, leading segments, and regional analysis. Key actors, major alliances, merger & acquisitions, and upcoming and trending innovation are pointed out. Company policies are checked, showing better outcomes from a techno-commercial viewpoint. The report provides granular information & analysis on the size, share, growth, patterns, segment and forecast of the global market from 2020 – 2027.